Click for best price
Cancer Drug based on CART Market Size, Share 2023
A type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T cells are taken from a patient?s blood. Then the gene for a special receptor that binds to a certain protein on the patient?s cancer cells is added to the T cells in the laboratory. The special receptor is called a chimeric antigen receptor (CAR). Large numbers of the CAR T cells are grown in the laboratory and given to the patient by infusion. CAR T-cell therapy is used to treat certain blood cancers, and it is being studied in the treatment of other types of cancer. Also called chimeric antigen receptor T-cell therapy.
This report aims to provide a comprehensive presentation of the global market for Cancer Drug based on CAR-T, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Drug based on CAR-T. This report contains market size and forecasts of Cancer Drug based on CAR-T in global, including the following market information:
Global Cancer Drug based on CAR-T Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Drug based on CAR-T market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Allogeneic Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Drug based on CAR-T include Fosun Kite Biotechnology, Gilead Sciences, Novartis and Bristol-Myers Squibb, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Drug based on CAR-T companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Drug based on CAR-T Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Cancer Drug based on CAR-T Market Segment Percentages, by Type, 2022 (%)
Allogeneic
Autologous
Global Cancer Drug based on CAR-T Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Cancer Drug based on CAR-T Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Other
Global Cancer Drug based on CAR-T Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Cancer Drug based on CAR-T Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Drug based on CAR-T revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Drug based on CAR-T revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Fosun Kite Biotechnology
Gilead Sciences
Novartis
Bristol-Myers Squibb
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Drug based on CAR-T, market overview.
Chapter 2: Global Cancer Drug based on CAR-T market size in revenue.
Chapter 3: Detailed analysis of Cancer Drug based on CAR-T company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Drug based on CAR-T in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cancer Drug based on CAR-T Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
64 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Drug based on CAR-T Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Drug based on CAR-T Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Drug based on CAR-T Overall Market Size
2.1 Global Cancer Drug based on CAR-T Market Size: 2022 VS 2030
2.2 Global Cancer Drug based on CAR-T Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Drug based on CAR-T Players in Global Market
3.2 Top Global Cancer Drug based on CAR-T Companies Ranked by Revenue
3.3 Global Cancer Drug based on CAR-T Revenue by Companies
3.4 Top 3 and Top 5 Cancer Drug based on CAR-T Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Drug based on CAR-T Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Drug based on CAR-T Players in Global Market
3.6.1 List of Global Tier 1 Cancer Drug based on CAR-T Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Drug based on CAR-T Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Drug based on CAR-T Market Size Markets, 2022 & 2030
4.1.2 Allogeneic
4.1.3 Autologous
4.2 By Type - Global Cancer Drug based on CAR-T Revenue & Forecasts
4.2.1 By Type - Global Cancer Drug based on CAR-T Revenue, 2018-2023
4.2.2 By Type - Global Cancer Drug based on CAR-T Revenue, 2024-2030
4.2.3 By Type - Global Cancer Drug based on CAR-T Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Drug based on CAR-T Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Pharmacy
5.1.4 Other
5.2 By Application - Global Cancer Drug based on CAR-T Revenue & Forecasts
5.2.1 By Application - Global Cancer Drug based on CAR-T Revenue, 2018-2023
5.2.2 By Application - Global Cancer Drug based on CAR-T Revenue, 2024-2030
5.2.3 By Application - Global Cancer Drug based on CAR-T Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cancer Drug based on CAR-T Market Size, 2022 & 2030
6.2 By Region - Global Cancer Drug based on CAR-T Revenue & Forecasts
6.2.1 By Region - Global Cancer Drug based on CAR-T Revenue, 2018-2023
6.2.2 By Region - Global Cancer Drug based on CAR-T Revenue, 2024-2030
6.2.3 By Region - Global Cancer Drug based on CAR-T Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cancer Drug based on CAR-T Revenue, 2018-2030
6.3.2 US Cancer Drug based on CAR-T Market Size, 2018-2030
6.3.3 Canada Cancer Drug based on CAR-T Market Size, 2018-2030
6.3.4 Mexico Cancer Drug based on CAR-T Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cancer Drug based on CAR-T Revenue, 2018-2030
6.4.2 Germany Cancer Drug based on CAR-T Market Size, 2018-2030
6.4.3 France Cancer Drug based on CAR-T Market Size, 2018-2030
6.4.4 U.K. Cancer Drug based on CAR-T Market Size, 2018-2030
6.4.5 Italy Cancer Drug based on CAR-T Market Size, 2018-2030
6.4.6 Russia Cancer Drug based on CAR-T Market Size, 2018-2030
6.4.7 Nordic Countries Cancer Drug based on CAR-T Market Size, 2018-2030
6.4.8 Benelux Cancer Drug based on CAR-T Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cancer Drug based on CAR-T Revenue, 2018-2030
6.5.2 China Cancer Drug based on CAR-T Market Size, 2018-2030
6.5.3 Japan Cancer Drug based on CAR-T Market Size, 2018-2030
6.5.4 South Korea Cancer Drug based on CAR-T Market Size, 2018-2030
6.5.5 Southeast Asia Cancer Drug based on CAR-T Market Size, 2018-2030
6.5.6 India Cancer Drug based on CAR-T Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cancer Drug based on CAR-T Revenue, 2018-2030
6.6.2 Brazil Cancer Drug based on CAR-T Market Size, 2018-2030
6.6.3 Argentina Cancer Drug based on CAR-T Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Drug based on CAR-T Revenue, 2018-2030
6.7.2 Turkey Cancer Drug based on CAR-T Market Size, 2018-2030
6.7.3 Israel Cancer Drug based on CAR-T Market Size, 2018-2030
6.7.4 Saudi Arabia Cancer Drug based on CAR-T Market Size, 2018-2030
6.7.5 UAE Cancer Drug based on CAR-T Market Size, 2018-2030
7 Cancer Drug based on CAR-T Companies Profiles
7.1 Fosun Kite Biotechnology
7.1.1 Fosun Kite Biotechnology Company Summary
7.1.2 Fosun Kite Biotechnology Business Overview
7.1.3 Fosun Kite Biotechnology Cancer Drug based on CAR-T Major Product Offerings
7.1.4 Fosun Kite Biotechnology Cancer Drug based on CAR-T Revenue in Global Market (2018-2023)
7.1.5 Fosun Kite Biotechnology Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Cancer Drug based on CAR-T Major Product Offerings
7.2.4 Gilead Sciences Cancer Drug based on CAR-T Revenue in Global Market (2018-2023)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Cancer Drug based on CAR-T Major Product Offerings
7.3.4 Novartis Cancer Drug based on CAR-T Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Cancer Drug based on CAR-T Major Product Offerings
7.4.4 Bristol-Myers Squibb Cancer Drug based on CAR-T Revenue in Global Market (2018-2023)
7.4.5 Bristol-Myers Squibb Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Drug based on CAR-T Market Opportunities & Trends in Global Market
Table 2. Cancer Drug based on CAR-T Market Drivers in Global Market
Table 3. Cancer Drug based on CAR-T Market Restraints in Global Market
Table 4. Key Players of Cancer Drug based on CAR-T in Global Market
Table 5. Top Cancer Drug based on CAR-T Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Drug based on CAR-T Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Drug based on CAR-T Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Drug based on CAR-T Product Type
Table 9. List of Global Tier 1 Cancer Drug based on CAR-T Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Drug based on CAR-T Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Drug based on CAR-T Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Cancer Drug based on CAR-T Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Drug based on CAR-T Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Cancer Drug based on CAR-T Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Cancer Drug based on CAR-T Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Drug based on CAR-T Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Cancer Drug based on CAR-T Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Cancer Drug based on CAR-T Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Drug based on CAR-T Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Drug based on CAR-T Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Drug based on CAR-T Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Drug based on CAR-T Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Drug based on CAR-T Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Drug based on CAR-T Revenue, (US$, Mn), 2024-2030
Table 30. Fosun Kite Biotechnology Company Summary
Table 31. Fosun Kite Biotechnology Cancer Drug based on CAR-T Product Offerings
Table 32. Fosun Kite Biotechnology Cancer Drug based on CAR-T Revenue (US$, Mn) & (2018-2023)
Table 33. Fosun Kite Biotechnology Key News & Latest Developments
Table 34. Gilead Sciences Company Summary
Table 35. Gilead Sciences Cancer Drug based on CAR-T Product Offerings
Table 36. Gilead Sciences Cancer Drug based on CAR-T Revenue (US$, Mn) & (2018-2023)
Table 37. Gilead Sciences Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Cancer Drug based on CAR-T Product Offerings
Table 40. Novartis Cancer Drug based on CAR-T Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Bristol-Myers Squibb Company Summary
Table 43. Bristol-Myers Squibb Cancer Drug based on CAR-T Product Offerings
Table 44. Bristol-Myers Squibb Cancer Drug based on CAR-T Revenue (US$, Mn) & (2018-2023)
Table 45. Bristol-Myers Squibb Key News & Latest Developments
List of Figures
Figure 1. Cancer Drug based on CAR-T Segment by Type in 2022
Figure 2. Cancer Drug based on CAR-T Segment by Application in 2022
Figure 3. Global Cancer Drug based on CAR-T Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Drug based on CAR-T Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Cancer Drug based on CAR-T Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Drug based on CAR-T Revenue in 2022
Figure 8. By Type - Global Cancer Drug based on CAR-T Revenue Market Share, 2018-2030
Figure 9. By Application - Global Cancer Drug based on CAR-T Revenue Market Share, 2018-2030
Figure 10. By Type - Global Cancer Drug based on CAR-T Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Cancer Drug based on CAR-T Revenue Market Share, 2018-2030
Figure 12. By Application - Global Cancer Drug based on CAR-T Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Cancer Drug based on CAR-T Revenue Market Share, 2018-2030
Figure 14. By Region - Global Cancer Drug based on CAR-T Revenue Market Share, 2018-2030
Figure 15. By Country - North America Cancer Drug based on CAR-T Revenue Market Share, 2018-2030
Figure 16. US Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Cancer Drug based on CAR-T Revenue Market Share, 2018-2030
Figure 20. Germany Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2030
Figure 21. France Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Cancer Drug based on CAR-T Revenue Market Share, 2018-2030
Figure 28. China Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2030
Figure 32. India Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Cancer Drug based on CAR-T Revenue Market Share, 2018-2030
Figure 34. Brazil Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Cancer Drug based on CAR-T Revenue Market Share, 2018-2030
Figure 37. Turkey Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Cancer Drug based on CAR-T Revenue, (US$, Mn), 2018-2030
Figure 41. Fosun Kite Biotechnology Cancer Drug based on CAR-T Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Gilead Sciences Cancer Drug based on CAR-T Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Cancer Drug based on CAR-T Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bristol-Myers Squibb Cancer Drug based on CAR-T Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
